Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001826667-25-000108
Filing Date
2025-08-04
Accepted
2025-08-04 07:33:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9021
  Complete submission text file 0001826667-25-000108.txt   10723
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Subject) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91951 | Film No.: 251178011
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address BOX 984 BORAS V7 SE-501 10
Business Address BOX 984 BORAS V7 SE-501 10 46 (0) 705-27 13 50
Frankenius Equity AB (Filed by) CIK: 0001988262 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13D/A